Sorafenat (Sorafenib) tablets, for oral use. Initial U.S. Approval: 2005. Available in India.

Facilitator under Named Patient Supply.

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA. Indian Pharma Network (IPN) act as a facilitator for you, under Named Patient Supply for anti-cancer medicines.

For overseas patient " Sorafenat (Sorafenib) tablets " brands can be also made available to overseas patients, doctors and hospitals at China, Cambodia, Indonesia, Nepal, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

News / Update for Sorafenat (sorafenib).

For Sorafenat (Sorafenib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Experimental Targeted Therapy Pill Extends Lives of Patients with Metastatic Renal Cell Carcinoma For More Details

FDA Approves New Drug Combination to Treat Endometrial Cancer. For More Details